HOUSTON INNOVATORS PODCAST EPISODE 11

Houston Methodist executive to lead the hospital into the future of health care

Roberta Schwartz is leading the innovation efforts at Houston Methodist. Courtesy of Houston Methodist

It may come as no surprise to anyone who's met Roberta Schwartz that she's a self starter. Schwartz, who is the executive vice president and chief innovation officer for Houston Methodist, was among the group that organized to create what is now the Center for Innovation within the hospital system.

But one of her earlier moments of innovation leadership came when she was diagnosed with cancer at a young age. She co-founded the Young Survival Coalition to help connect young breast cancer patients like herself.

"I was 27 when I was unexpectedly diagnosed with breast cancer — I have no family history, no cancer in the family. It certainly was a shock to my system," Schwartz says on this week's episode of the Houston Innovators Podcast. "Once I was diagnosed, and through some of the original surgery and care I had to do, I knew that I wanted to reach out and find a larger community of young women."

Now, in her role at Houston Methodist, Schwartz hopes to help cultivate new avenues of innovation within health care — from wearable technology and virtual reality to a human resources chatbot and a patient messaging platform.

Schwartz discusses these new technologies — as well as a new tech hub the hospital system is working on to demonstrate the future of health care — in the episode. Stream the episode below and subscribe wherever you get your podcasts.


Trending News

Building Houston

 
 

A new report says Houston “is poised for further growth” in life sciences. Photo via Getty Images

Houston is receiving more kudos for its robust life sciences sector.

Bayou City lands at No. 13 in JLL’s 2022 ranking of the country’s top 15 metro areas for life sciences. JLL says Houston “is poised for further growth” in life sciences.

Here’s how Houston fares in each of the ranking’s three categories:

  • No. 12 for supply of life sciences-oriented commercial real estate
  • No. 14 for access to life sciences talent
  • No. 15 for life sciences grant funding and venture capital

Earlier this year, Houston scored a 13th-place ranking on a list released by JLL competitor CBRE of the country’s top 25 life sciences markets. Meanwhile, commercial real estate platform CommercialCafe recently placed Houston at No. 10 among the top U.S. metros for life sciences.

JLL applauds Houston for strong growth in the amount of life sciences talent along with “an impressive base of research institutions and medical centers.” But it faults Houston for limited VC interest in life sciences startups and a small inventory of lab space.

“Houston is getting a boost [in life sciences] from the growing Texas Medical Center and an influx of venture capital earmarked for life sciences research,” the Greater Houston Partnership recently noted.

Boston appears at No. 1 in this year’s JLL ranking, followed by the San Francisco Bay Area, San Diego, Washington, D.C./Baltimore, and Philadelphia.

Last year’s JLL list included only 10 life sciences markets; Houston wasn’t among them.

“The long-term potential of the sector remains materially unchanged since 2021,” Travis McCready, head of life sciences for JLL’s Americas markets, says in a news release.

“Innovation is happening at a more rapid pace than ever before, the fruits of research into cell and gene therapy are just now being harvested, and revenue growth has taken off in the past five years as the sector becomes larger, an atypical growth track.”

Trending News